US Respiratory& Sleep Management Device Market Growing

The US respiratory and sleep management device market is steadily growing.

Oxygen therapy is the preferred treatment for chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the US. As the US population ages, COPD is expected to become more prevalent, and thus the market for oxygen therapy will continue to grow, especially for portable oxygen devices.

With 80% of obstructive sleep apnea (OSA) sufferers remaining undiagnosed in the US, the OSA testing and therapeutic device market also holds significant potential.

Increased awareness of OSA among both physicians and patients will result in a surge of diagnosis and therapy. With the threat of national health emergencies, such as SARS and, more recently, H1N1, national and state-wide stockpiling of ventilators will continue to drive the ventilator market.

This report examines the market potential and competitive landscape of each segment, including detailed analyses of unit sales, average selling prices (ASPs), market revenues, and competitors’ market shares.